Alen Zabotti, Filippo Fagni, Laure Gossec, Ivan Giovannini, Michael Sticherling, Annarita Tullio, Xenofon Baraliakos, Gabriele De Marco, Salvatore De Vita, Enzo Errichetti, Luca Quartuccio, Ettore Silvagni, Josef S Smolen, Ilaria Tinazzi, Abdulla Watad, Georg Schett, Dennis G McGonagle, David Simon
OBJECTIVE: Subjects with subclinical psoriatic arthritis (PsA), defined as the presence of arthralgia in psoriasis (PsO), are at higher risk of PsA but scant real-world data exist. Our aims were to (1) estimate the probability of PsA development in subclinical PsA, (2) characterise subclinical PsA symptoms and (3) determine the clinical patterns at PsA diagnosis. METHODS: Patients with PsO, mainly subclinical PsA, were evaluated longitudinally in two European cohorts...
April 10, 2024: RMD Open